Yupei Yuan, MD

Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing

Disclosures:

Presentations

Sep 28

2532 - A Phase II Trial of Safety and Efficacy of Radiotherapy Combined with Anlotinib in Locally Advanced Non-Small Cell Lung Cancer Patients Intolerable to Concurrent Chemoradiotherapy: Preliminary Surviva
Hall F
04:45pm - 06:00pm PT
Sep 30

3575 - Effect of Prophylactic Thrombopoietin and Magnetic Resonance Guided Bone Marrow-Sparing Concurrent Chemoradiotherapy on Thrombocytopenia for Thoracic Esophageal Cancer: Final Analysis of a Phase II St
Hall F
02:30pm - 03:45pm PT